About Genflow Biosciences
Genflow Biosciences is a company based in Charleroi (Belgium) founded in 2020 by Eric Leire. It operates as a HealthTech. Genflow Biosciences offers products and services including GF-1002. Genflow Biosciences operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
- Headquarter Charleroi, Belgium
- Founders Eric Leire
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genflow Biosciences Plc
-
Annual Revenue
$0 (USD)0as on Dec 31, 2024
-
Net Profit
$-1.99 M (USD)2.55as on Dec 31, 2024
-
EBITDA
$-2.39 M (USD)-6.06as on Dec 31, 2024
-
Latest Funding Round
$1.31 M (USD), Grant
Oct 22, 2024
-
Investors
Wallonia
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Genflow Biosciences
Genflow Biosciences is a publicly listed company on the LSE with ticker symbol GENF in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Genflow Biosciences
Genflow Biosciences offers a comprehensive portfolio of products and services, including GF-1002. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A compound targeting aging through SIRT6 gene delivery.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Genflow Biosciences
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.3M
-
First Round
First Round
(16 Mar 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Grant - Genflow Biosciences | Valuation |
investors |
|
| Apr, 2024 | Amount | Post-IPO - Genflow Biosciences | Valuation |
investors |
|
| Mar, 2022 | Amount | Grant - Genflow Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genflow Biosciences
Genflow Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wallonia and Capital Plus Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Access to government programs and development services is facilitated.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genflow Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genflow Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genflow Biosciences Comparisons
Competitors of Genflow Biosciences
Genflow Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Services for cell therapy development and manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Development and manufacturing services for cell-based therapies are provided.
|
|
| domain | founded_year | HQ Location |
Stem cell-based therapy services for research solutions are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genflow Biosciences
Frequently Asked Questions about Genflow Biosciences
When was Genflow Biosciences founded?
Genflow Biosciences was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Genflow Biosciences located?
Genflow Biosciences is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Who is the current CEO of Genflow Biosciences?
Eric Leire is the current CEO of Genflow Biosciences. They have also founded this company.
What does Genflow Biosciences do?
Genflow Biosciences is engaged in the research and development of novel therapeutic solutions aimed at slowing or halting the aging process in humans and dogs. Based in the UK, the company operates with RD facilities in Belgium and focuses on innovative gene therapies, such as the GF-1002 compound, which utilizes a centenarian variant of the SIRT6 gene. Their work targets the reduction of healthcare costs and addresses social challenges associated with aging populations through direct intervention in biological aging mechanisms.
Who are the top competitors of Genflow Biosciences?
Genflow Biosciences's top competitors include Ori Biotech, MaSTherCell and Orgenesis.
What products or services does Genflow Biosciences offer?
Genflow Biosciences offers GF-1002.
Is Genflow Biosciences publicly traded?
Yes, Genflow Biosciences is publicly traded on LSE under the ticker symbol GENF.
Who are Genflow Biosciences's investors?
Genflow Biosciences has 2 investors. Key investors include Wallonia, and Capital Plus Partners.
What is Genflow Biosciences's ticker symbol?
The ticker symbol of Genflow Biosciences is GENF on LSE.